Hybrid Financing in Life Sciences: Unlocking Growth Amid Market Challenges
Life sciences companies and investors continue to navigate a complex and challenging investment landscape – marked by high interest rates, a volatile regulatory environment, tight venture capital (VC) markets, and slowly rebounding initial public offering …